Volver a Agenda
Session Chair(s)
Noriaki Murao, DIAFellow, MS
Senior Consultant (Pharmaceuticals)
NM Consulting, Japan
Learning Objective : Discuss the current epidemiology and developments of rare diseases in Asia including how these achievements affect other countries; Describe the orphan drug legislation and status of orphan drug development in Japan.
Speaker(s)
Government Challenges and Initiatives on Rare Diseases in Asia
Hiroshi Mizushima, PHD
National Institute of Public Health, Japan
Chief Senior Researcher, Center for Public Health Informatics
Developing Treatments of Rare Diseases in Asia
Wuh-Liang Hwu, MD, PHD
National Taiwan University, Taiwan
Professor in Pediatrics
Japanese Regulation on Orphan Medicines and Drug Development in Rare Diseases
Harumasa Nakamura, MD, PHD
National Center of Neurology and Psychiatry, Japan
Director of Department of Clinical Research Support,
¿Tiene una cuenta?